AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Gerard Lacourciere

Appears inactive Last observed office action: November 2014 (136 months ago).

Examiner Gerard Lacourciere appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 65.2%, they average 1.49 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Easy
Difficulty vs Group Very Easy
Difficulty vs TC Very Easy
Difficulty vs USPTO Very Easy
Average OA / Grant 1.49
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
3 years (2012-2014)
Tech Center
1600 - Biotechnology and Organic
Group
1650 - Enzymology, Microbiology, and Fermentation

Metrics

Applications Evaluated
69
Granted Applications
45
Non-Granted Applications
24
Avg OA / Grant
1.49
Last OA Observed
November 2014 (136 months ago)
Art Units Seen
1656
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 65.2% 1.49
Art Unit 27 48.1% 1.73
Group 207 41.1% 2.01
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2012 2013 2014
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2012; examiner may not yet have been active in the available dataset.
2012 1 1 100.0%
2013 36 22 61.1%
2014 32 22 68.8%
No observed data after 2014; examiner may have gone inactive or moved out of examining work.

45 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 69 1.4% 13.0% 78.3% 4.3%
2 34 0.0% 8.8% 88.2% 2.9%
3 5 0.0% 0.0% 100.0% 0.0%
4 1 0.0% 0.0% 100.0% 0.0%
5 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

0.0%
2012
0.0%
2013
2.4%
2014

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.